Difficulty: Medium
Average Score: 81%
Practice
An 81-year-old female presents to the emergency department with a racing heartbeat. She is subsequently placed on continuous ECG monitor and irregular rhythm is seen. The diagnosis of atrial fibrillation is made. She is started on an amiodarone drip. What side effect should the physician be aware of when starting amiodarone?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Pulmonary fibrosis. Amiodarone is a potent antiarrhythmic medication commonly used to treat atrial fibrillation. Pulmonary fibrosis is a known side effect of amiodarone therapy, which can be serious and life-threatening. This adverse effect occurs due to the drug's propensity to deposit in lung tissue, leading to inflammation and fibrosis.
Option B) Impotence is incorrect as it is not a commonly associated side effect of amiodarone. Option C) Lupus-like syndrome is also incorrect as this is not a typical side effect of amiodarone therapy. Option D) Prolongation of AV refractory period is an expected pharmacological effect of amiodarone, but it is not the specific side effect that the physician should be particularly aware of in this case.
Educationally, understanding the side effects of medications is crucial for healthcare providers to make informed decisions about treatment options and to monitor patients effectively. In the case of amiodarone, recognizing the potential for pulmonary fibrosis is essential for early detection and management to prevent serious complications. This knowledge helps ensure patient safety and optimal outcomes in clinical practice.
Option B) Impotence is incorrect as it is not a commonly associated side effect of amiodarone. Option C) Lupus-like syndrome is also incorrect as this is not a typical side effect of amiodarone therapy. Option D) Prolongation of AV refractory period is an expected pharmacological effect of amiodarone, but it is not the specific side effect that the physician should be particularly aware of in this case.
Educationally, understanding the side effects of medications is crucial for healthcare providers to make informed decisions about treatment options and to monitor patients effectively. In the case of amiodarone, recognizing the potential for pulmonary fibrosis is essential for early detection and management to prevent serious complications. This knowledge helps ensure patient safety and optimal outcomes in clinical practice.